Replication of Hepatitis B Virus

Zakim and Boyer's Hepatology

Volumn , Issue , 2012, Pages 86-96

  Warner, Nadia ^a   Locarnini, Stephen ^a  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882475164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0881-3.00006-1     Document Type: Chapter

References (96)

1. Seeger C, Zoulim F, Mason WS Hepadnaviruses. Fields virology 2007, 2977-3030. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
2. Schaefer S Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 2007, 13(1):14-21.
3. Stuyver L, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000, 81(Pt 1):67-74.
4. Simmonds P, Midgley S Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 2005, 79(24):15467-15476.
5. Yang J, et al. Identification of Hepatitis B virus putative intergenotype recombinants by using fragment typing. J Gen Virol 2006, 87(Pt 8):2203-2215.
6. Kao JH, Liu CJ, Chen DS Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002, 36(2):303-304.
7. Sugiyama M, et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006, 44(4):915-924.
8. Courouce-Pauty AM, Plancon A, Soulier JP Distribution of HBsAg subtypes in the world. Vox Sang 1983, 44(4):197-211.
9. Okamoto H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988, 69(Pt 10):2575-2583.
10. Norder H, Courouce AM, Magnius LO Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992, 73(Pt 12):3141-3145.
11. Wallace LA, Carman WF Surface gene variation of HBV: scientific and medical relevance. J Viral Hepat 1997, 3(1):5-16.
12. Moriya T, et al. Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit. J Clin Microbiol 2002, 40(3):877-880.
13. Gripon P, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002, 99:15655-15660.
14. Walter EK, et al. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24(1):1-5.
15. Ren S, Nassal M Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary Tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J Virol 2001, 75(3):1104-1116.
16. Delaney WEIV, Isom HC Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 1998, 28(4):1134-1146.
17. Durantel D, et al. A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus. Hepatology 2004, 40(4):855-864.
18. Gunther S, et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995, 69:5437-5444.
19. Yang H, et al. In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector. Antiviral Res 2004, 61(1):27-36.
20. Delaney WE, et al. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro. Antimicrob Agents Chemother 2004, 48(10):3702-3710.
21. Ganem D, Schneider R Hepadnaviridae: the viruses and their replication. Fields virology 2001, 2923-2970. Lippincott-Raven, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
22. Heermann KH, et al. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984, 52(2):396-402.
23. Gunther S, et al. Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 1997, 238(2):363-371.
24. Soussan P, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000, 105(1):55-60.
25. Lee JY, et al. Duck hepatitis B virus replication in primary bile duct epithelial cells. J Virol 2001, 75(16):7651-7661.
26. Seeger C, Mason WS Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64(1):51-68.
27. De Meyer S, et al. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J Viral Hepat 1997, 4(3):145-153.
28. Pontisso P, et al. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 1989, 173(2):522-530.
29. Neurath AR, et al. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986, 46(3):429-436.
30. Urban S, Gripon P Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol 2002, 76(4):1986-1990.
31. Glebe D, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and Tupaia hepatocytes. Gastroenterology 2005, 129(1):234-245.
32. Gripon P, Cannie I, Urban S Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 2005, 79(3):1613-1622.
33. Glebe D, et al. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 2003, 77(17):9511-9521.
34. Chouteau P, et al. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol 2001, 75(23):11565-11572.
35. De Falco S, et al. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 2001, 276:36613-36623.
36. Kann M, Gerlich W Hepadnaviridae: structure and molecular virology. Viral hepatitis 1998, 77-105. Churchill Livingstone, London. A. Zuckerman, H. Thomas (Eds.).
37. Rabe B, et al. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 2003, 100(17):9849-9854.
38. Bock CT, et al. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994, 8(3):215-229.
39. Newbold JE, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995, 69(6):3350-3357.
40. Kock J, et al. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary Tupaia hepatocytes. Hepatology 2003, 38(6):1410-1418.
41. Newbold JE, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995, 69:3350-3357.
42. Doitsh G, Shaul Y A long HBV transcript encoding pX is inefficiently exported from the nucleus. Virology 2003, 309(2):339-349.
43. Yang W, Summers J Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J Virol 1995, 69(7):4029-4036.
44. Bruss V, Ganem D The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991, 88(3):1059-1063.
45. Gerelsaikhan T, Tavis JE, Bruss V Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis. J Virol 1996, 70(7):4269-4274.
46. Loffler-Mary H, et al. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology 2000, 270(2):358-367.
47. Eble BE, et al. Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 1987, 7(10):3591-3601.
48. Eble BE, Lingappa VR, Ganem D The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J Virol 1990, 64(3):1414-1419.
49. Fernholz D, et al. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 1993, 194(1):137-148.
50. Tron F, et al. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences. J Infect Dis 1989, 160(2):199-204.
51. Bruss V, et al. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J 1994, 13(10):2273-2279.
52. Ostapchuk P, Hearing P, Ganem D A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J 1994, 13(5):1048-1057.
53. Prange R, Streeck RE Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J 1995, 14(2):247-256.
54. Persing DH, Varmus HE, Ganem D The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 1987, 61(5):1672-1677.
55. Gripon P, et al. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995, 213(2):292-299.
56. Bruss V, Vieluf K Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol 1995, 69(11):6652-6657.
57. Le Seyec J, et al. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 1999, 73(3):2052-2057.
58. Lambert C, Prange R Posttranslational N-glycosylation of the hepatitis B virus large envelope protein. Virol J 2007, 4(1):45.
59. Schmitt S, et al. Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem 1999, 274(17):11945-11957.
60. Werr M, Prange R Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J Virol 1998, 72(1):778-782.
61. Schmitt S, et al. Structure of pre-S2 N- and O-linked glycans in surface proteins from different genotypes of hepatitis B virus. J Gen Virol 2004, 85(Pt 7):2045-2053.
62. Kimura T, et al. Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain. J Biol Chem 2005, 280(23):21713-21719.
63. Laub O, et al. Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region. J Virol 1983, 48(1):271-280.
64. Liu CC, Yansura D, Levinson AD Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector. DNA 1982, 1(3):213-221.
65. Persing DH, Varmus HE, Ganem D A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin. Proc Natl Acad Sci U S A 1985, 82(10):3440-3444.
66. Ou JH, Rutter WJ Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol 1987, 61(3):782-786.
67. Persing DH, Varmus HE, Ganem D Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 1986, 234(4782):1388-1391.
68. Wounderlich G, Bruss V Characterization of early hepatitis B virus surface protein oligomers. Arch Virol 1996, 141(7):1191-1205.
69. Valenzuela P, et al. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982, 298(5872):347-350.
70. Patzer EJ, et al. Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol 1986, 58(3):884-892.
71. Huovila AP, Eder AM, Fuller SD Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 1992, 118(6):1305-1320.
72. Rost M, et al. Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation. J Biol Chem 2006, 281(39):29297-29308.
73. Watanabe T, et al. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A 2007, 104(24):10205-10210.
74. Lu X, et al. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virology 1995, 213(2):660-665.
75. Will H, et al. Replication strategy of human hepatitis B virus. J Virol 1987, 61(3):904-911.
76. Ganem D, Pollack JR, Tavis J Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis 1994, 3(2-3):85-93.
77. Bartholomeusz A, Tehan BG, Chalmers DK Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther 2004, 9(2):149-160.
78. Warner N, Locarnini S The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008, 48(1):88-98.
79. Wynne SA, Crowther RA, Leslie AG The crystal structure of the human hepatitis B virus capsid. Mol Cell 1999, 3(6):771-780.
80. Ponsel D, Bruss V Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol 2003, 77(1):416-422.
81. Zlotnick A, et al. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 1996, 35(23):7412-7421.
82. Hadziyannis SJ, Vassilopoulos D Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001, 34(4 Pt 1):617-624.
83. Visvanathan K, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45(1):102-110.
84. Milich D, Liang TJ Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003, 38:1075-1086.
85. Zoulim F, Saputelli J, Seeger C Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994, 68:2026-2030.
86. Starkman SE, et al. Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 2003, 314(1):381-393.
87. Zhang Z, et al. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol 2004, 78(9):4566-4572.
88. Rahmani Z, et al. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000, 74(6):2840-2846.
89. Bouchard MJ, Schneider RJ The enigmatic X gene of hepatitis B virus. J Virol 2004, 78(23):12725-12734.
90. Huang J, et al. Proteasome complex as a potential cellular target of hepatitis H virus X protein. J Virol 1996, 70(8):5582-5591.
91. Bouchard MJ, Wang LH, Schneider RJ Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001, 294(5550):2376-2378.
92. Chen PJ, et al. Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. J Virol 1989, 63(10):4165-4171.
93. Su TS, et al. Analysis of hepatitis B virus transcripts in infected human livers. Hepatology 1989, 9:180-185.
94. Soussan P, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000, 105:55-60.
95. Soussan P, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol 2003, 38(3):343-348.
96. Rosmorduc O, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 1995, 22(1):10-19.